---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-23-033396"
form_type: "8-K"
ticker: "AIM"
cik: "0000946644"
company_name: "AIM ImmunoTech Inc."
filed_at: "2023-09-22T23:59:59+00:00"
generated_at: "2026-06-10T10:00:38.352841+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "medium"
source: SEC EDGAR
---

# AIM ImmunoTech to present Ampligen oncology data at Roswell Park symposium

## Summary
- Chris McAleer, Ph.D., Scientific Officer, will present at the Marie Sklodowska-Curie Symposium on Cancer Research and Care at Roswell Park.
- Company also sponsors the symposium; presentation titled 'Rintatolimod (Ampligen): Overview of Ampligen’s Clinical Progress in Oncology'.
- No new clinical results or financial data disclosed in the filing.

## SEC filing metadata
- accession: 0001493152-23-033396
- form_type: 8-K
- ticker: AIM
- cik: 0000946644
- company_name: AIM ImmunoTech Inc.
- filed_at: 2023-09-22T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: medium
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/946644/000149315223033396/0001493152-23-033396-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/946644/000149315223033396/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-23-033396
- JSON: https://secwatch.observer/filing/0001493152-23-033396.json
- Plain text: https://secwatch.observer/filing/0001493152-23-033396.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.